Antibody Industrial Symposium 2017

Events
… from various horizons, as Antibody-Drug Conjugates (ADCs) bring together people with many skills and various … physicians and policy makers to exchange about therapeutic ADCs. Mr David Wyngaert, Business Development Director & Dr …

Media library

Basic page
… New Chemical Entities (incl. peptides, oligonucleotides), Nanomedicine products, Vaccines, Cell-Based and Gene Therapy …

Characterisation of proteins by MS

Services
… range of technologies to fully characterise therapeutic proteins. Whether you are interested in monoclonal … antibodies (mAbs), antibody-drug conjugates (ADCs), fusion proteins, small or large proteins, Quality Assistance has the tools to support you …

Products

Basic page
… New Chemical Entities (incl. peptides, oligonucleotides), Nanomedicine products, Vaccines, Cell-Based and Gene Therapy …

NBEs (New Biological Entities)

Products
… teams are here to support your developments for mAbs, ADCs and proteins. … … NBEs (New Biological Entities) …
Resources
… Anti body-Drug Conjugates (ADCs) are anti bodies engineered to deliver a cytotoxic …